• E. Del Bianco
  • G. Muscarella
  • P. Cappugi


Sclerotherapy consists of the intravenous injection of sclerosing agents that produce damage of endothelial cells and cause thromboses, fibroses, and stenoses.


Hypertonic Saline Varicose Vein Serum Ferritin Level Graduate Compression Stocking Cutaneous Necrosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    American Academy of Dermatology (1996) Guidelines of care for sclerotherapy treatment of varicose and telangiectatic leg veins. J Am Acad Dermatol 34 (3): 523–528Google Scholar
  2. 2.
    Weiss RA, Goldman MP (1995) Advances in sclerotherapy. Dermatol Clin 13 (2): 431–445PubMedGoogle Scholar
  3. 3.
    Conrad P, Malouf GM, Stacey MC (1995) The Australian polidocanol (Aethoxysklerol) study. Results at two years. Dermatol Surg 21 (4): 334–336PubMedCrossRefGoogle Scholar
  4. 4.
    Higgins TT, Kittel PB (1939) The use of sodium morrhuate in treatment of varicose veins by injection. Lancet 1: 68–69Google Scholar
  5. 5.
    Zummo M (1991) Choosing the sclerosing solution in sclerotherapy. In: Raymond-Martinpeau P (ed) Phlebologia. Houston, pp 143–147Google Scholar
  6. 6.
    Green D (1998) Sclerotherapy for the permanent eradication of varicose veins: theoretical and practical considerations. J Am Acad Dermatol 38: 461–475PubMedCrossRefGoogle Scholar
  7. 7.
    Goldman NW, Sadick NS, Weiss RA (1995) Cutaneous necrosis, telangiectatic matting, and hyper-pigmentation following sclerotherapy. Etiology, prevention, and treatment. Dermatol Surg 21 (1): 19–29PubMedCrossRefGoogle Scholar
  8. 8.
    Scott C, Seiger E (1997) Postsclerotherapy pigmentation. Is serum ferritin level an accurate indicator? Dermatol Surg 23 (4): 281–282PubMedCrossRefGoogle Scholar
  9. 9.
    Weiss RA, Weiss MA (1990) Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonic saline vs. polidocanol. J Dermatol Surg Oncol 16: 800PubMedCrossRefGoogle Scholar
  10. 10.
    Goldman PM (1989). Polidocanol (Aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias. J Dermatol Surg Oncol 15: 204PubMedCrossRefGoogle Scholar
  11. 11.
    Puissegur Lupo ML (1989) Sclerotherapy: review of results and complications in 200 patients. Dermatol Surg Oncol 15: 214CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • E. Del Bianco
  • G. Muscarella
  • P. Cappugi

There are no affiliations available

Personalised recommendations